» Articles » PMID: 34921343

Low Fluctuation of Symptoms May Delay Diagnosis of Myasthenia Gravis: A Case Series

Overview
Journal Neurol Ther
Publisher Springer
Specialty Neurology
Date 2021 Dec 18
PMID 34921343
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Myasthenia gravis is an autoimmune disorder affecting neuromuscular transmission, and its hallmark is fluctuating muscular weakness affecting the ocular, bulbar, respiratory, or limb muscles. Our objective is to highlight the difficulties encountered in diagnosing this disorder in patients lacking this characteristic phenomenon.

Methods: Three cases of patients presenting with progressive weakness of bulbar and ocular muscles, in whom a lack of fluctuation delayed the diagnosis of myasthenia gravis, are described.

Results: Amyotrophic lateral sclerosis was considered in two of the patients, while cavernous sinus thrombosis was initially diagnosed in the third. Electrodiagnostic, pharmacologic, and serologic testing ultimately established the diagnosis of myasthenia gravis.

Conclusion: While the typical clinical pattern of myasthenia gravis is well known and easily recognizable, there are cases when the diagnosis, and thus the treatment, is delayed because of low or absent fluctuation of symptoms. The acknowledgment of this probably underestimated presentation is important for expeditious management.

Citing Articles

Factors affecting the diagnostic delay of myasthenia gravis.

Marlet I, Andersen R, Axelsen K, Andersen L, Vissing J, Witting N J Neurol. 2024; 272(1):29.

PMID: 39665854 DOI: 10.1007/s00415-024-12807-1.


The impact of diagnosis delay on European patients with generalised myasthenia gravis.

Cortes-Vicente E, Borsi A, Gary C, Noel W, Lee J, Karmous W Ann Clin Transl Neurol. 2024; 11(9):2254-2267.

PMID: 39090840 PMC: 11537147. DOI: 10.1002/acn3.52122.

References
1.
Gilhus N . Myasthenia Gravis. N Engl J Med. 2016; 375(26):2570-2581. DOI: 10.1056/NEJMra1602678. View

2.
Hehir M, Silvestri N . Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology. Neurol Clin. 2018; 36(2):253-260. DOI: 10.1016/j.ncl.2018.01.002. View

3.
Lazaridis K, Tzartos S . Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management. Front Neurol. 2020; 11:596981. PMC: 7734299. DOI: 10.3389/fneur.2020.596981. View

4.
Benatar M . A systematic review of diagnostic studies in myasthenia gravis. Neuromuscul Disord. 2006; 16(7):459-67. DOI: 10.1016/j.nmd.2006.05.006. View

5.
Nicolau S, Liewluck T . TFG: At the crossroads of motor neuron disease and myopathy. Muscle Nerve. 2019; 60(6):645-647. DOI: 10.1002/mus.26692. View